Не сдохни! Еда в борьбе за жизнь

^{‹‹19››.} Smith DA. ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults. Ann Intern Med. 2012;157(12):JC6–5.

^{‹‹20››.} Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. JAMA. 1953;152(12):1090–3.

^{‹‹21››.} Strong JP. Landmark perspective: Coronary atherosclerosis in soldiers. A clue to the natural history of atherosclerosis in the young. JAMA. 1986;256(20):2863–6.

^{‹‹22››.} Voller RD, Strong WB. Pediatric aspects of atherosclerosis. Am Heart J. 1981;101(6): 815–36.

^{‹‹23››.} Napoli C, D’Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100(11):2680–90.

^{‹‹24››.} Benjamin MM, Roberts WC. Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease. Proc (Bayl Univ Med Cent). 2013;26(2):124–36.

^{‹‹25››.} McMahan CA, Gidding SS, Malcom GT, et al. Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis. Pediatrics. 2006; 118(4): 1447–55.

^{‹‹26››.} Trumbo PR, Shimakawa T. Tolerable upper intake levels for trans fat, saturated fat, and cholesterol. Nutr Rev. 2011;69(5):270–8.

^{‹‹27››.} Roberts WC. It’s the cholesterol, stupid! Am J Cardiol. 2010;106(9):1364–6.

^{‹‹28››.} O’Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R. Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol. 2004;43(11): 2142–6.

^{‹‹29››.} Esselstyn CB. In cholesterol lowering, moderation kills. Cleve Clin J Med. 2000;67(8):560–4.

^{‹‹30››.} Roberts WC. The cause of atherosclerosis. Nutr Clin Pract. 2008;23(5):464–7.

^{‹‹31››.} Roberts WC. The cause of atherosclerosis. Nutr Clin Pract. 2008;23(5):464–7.

^{‹‹32››.} King S. The best selling drugs since 1996 — why AbbVie’s Humira is set to eclipse Pfizer’s Lipitor. http://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996-why-abbvies-humira-is-set-to-eclipse-pfi zers-lipitor/. July 15, 2013. Accessed May 1, 2015.

^{‹‹33››.} Ginter E, Kajaba I, Sauša M. Addition of statins into the public water supply? Risks of side effects and low cholesterol levels. Cas Lek Cesk. 2012;151(5):243–7.

^{‹‹34››.} Ferenczi EA, Asaria P, Hughes AD, Chaturvedi N, Francis DP. Can a statin neutralize the cardiovascular risk of unhealthy dietary choices? Am J Cardiol. 2010;106(4):587–92.

^{‹‹35››.} Draeger A, Monastyrskaya K, Mohaupt M, et al. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol. 2006;210(1):94–102.

^{‹‹36››.} Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in communitydwelling older adults. Q JM. 2009;102(9):625–33.

^{‹‹37››.} Jefferson E. FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. http://www.fda.gov/NewsEvents/Newsroom/Press_Announcements/ ucm293623.htm. February 28, 2012. Accessed February 14, 2015.

^{‹‹38››.} McDougall JA, Malone KE, Daling JR, Cushing-Haugen KL, Porter PL, Li CI. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev. 2013;22(9):1529–37.